|
⚲
|
| Keyboard |
| Royalty Pharma Investments 2019 ICAV
✚
|
|
|---|---|
| CIK # | 0001909645 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001909645] | |
| 4 | [0001909645] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| RPI Finance Trust | |
| Royalty Pharma Investments 2019 ICAV | |
| Legorreta Pablo G | |
| Epizyme Inc | |
| RP Management LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2022-08-12 | Tender | 31,933,334 | ||
|
Epizyme Inc EPZM
Restricted Stock Units · derivative
|
2022-08-12 | Disposed to issuer | 8,060 | $0.00 | |
|
Epizyme Inc EPZM
Restricted Stock Units · derivative
|
2022-08-12 | Disposed to issuer | 8,994 | $0.00 | |
|
Epizyme Inc EPZM
Restricted Stock Units · derivative
|
2022-05-17 | Grant | 8,994 | $0.00 | |
|
Epizyme Inc EPZM
Stock Option (Right to Buy) · derivative
|
2022-05-17 | Grant | 41,006 | $0.56 | 22,963 |